tm logo
EVERY IMMUNE SYSTEM HAS A STORY TO TELL. THE KEY IS KNOWING HOW TO LISTEN.
Live/Registered
REGISTERED

on 09 Jul 2024

Last Applicant/ Owned by

1551 Eastlake Avenue E, Suite 200

Seattle

WA

98102

Serial Number

90459471 filed on 11th Jan 2021

Registration Number

7443900 registered on 09th Jul 2024

in the Principal Register

Correspondent Address

Hoang-chi Truong

Hoang-chi Truong Patent Law Works LLP

SALT LAKE CITY, UT 84107

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

EVERY IMMUNE SYSTEM HAS A STORY TO TELL. THE KEY IS KNOWING HOW TO LISTEN.

Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scien Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services


First Use Date in General

31st Jul 2020

First Use Date in Commerce

31st Jul 2020

Specimens


EVERY IMMUNE SYSTEM HAS A STORY TO TELL. THE KEY IS KNOWING HOW TO LISTEN. specimenEVERY IMMUNE SYSTEM HAS A STORY TO TELL. THE KEY IS KNOWING HOW TO LISTEN. specimenEVERY IMMUNE SYSTEM HAS A STORY TO TELL. THE KEY IS KNOWING HOW TO LISTEN. specimenEVERY IMMUNE SYSTEM HAS A STORY TO TELL. THE KEY IS KNOWING HOW TO LISTEN. specimenEVERY IMMUNE SYSTEM HAS A STORY TO TELL. THE KEY IS KNOWING HOW TO LISTEN. specimen

Mark Details


Serial Number

No 90459471

Mark Type

No Service Mark

Attorney Docket Number

No 10214-2-040

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
09th Jul 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
09th Jul 2024REGISTERED-PRINCIPAL REGISTER
31st May 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
31st May 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
30th May 2024STATEMENT OF USE PROCESSING COMPLETE
28th May 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
30th Apr 2024TEAS STATEMENT OF USE RECEIVED
04th Nov 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02th Nov 2023SOU EXTENSION 4 GRANTED
02th Nov 2023SOU EXTENSION 4 FILED